Inforlife Drug Patent Portfolio

Inforlife owns 2 orange book drugs protected by 2 US patents Given below is the list of Inforlife's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10888534 Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags 26 Apr, 2039
Active
US10966990 Midazolam in flexible bags 20 Jun, 2038
Active


Given below is the list of recent legal activities going on the following drug patents of Inforlife.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 26 Jun, 2024 US10888534
Payment of Maintenance Fee, 4th Year, Large Entity 25 Aug, 2023 US10568850 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 24 Mar, 2023 US10420735 (Litigated)
Recordation of Patent Grant Mailed 14 Mar, 2023 US11602508
Patent Issue Date Used in PTA Calculation 14 Mar, 2023 US11602508
Mail Post Card 09 Mar, 2023 US11602508
Email Notification 01 Mar, 2023 US11602508
Email Notification 23 Feb, 2023 US11602508
Issue Notification Mailed 22 Feb, 2023 US11602508
Dispatch to FDC 10 Feb, 2023 US11602508
Application Is Considered Ready for Issue 10 Feb, 2023 US11602508
Mail Notice of Allowance 06 Feb, 2023 US11602508
Issue Fee Payment Verified 06 Feb, 2023 US11602508
Issue Fee Payment Received 06 Feb, 2023 US11602508
Notice of Allowance Data Verification Completed 01 Feb, 2023 US11602508


Inforlife's Family Patents

Inforlife drugs have patent protection in a total of 2 countries. It has a significant patent presence in the US with 66.7% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Inforlife Drug List

Given below is the complete list of Inforlife's drugs and the patents protecting them.


1. Midazolam In 0.9% Sodium Chloride

Midazolam In 0.9% Sodium Chloride is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10966990 Midazolam in flexible bags 20 Jun, 2038
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Midazolam In 0.9% Sodium Chloride's drug page


2. Norepinephrine Bitartrate In 0.9% Sodium Chloride

Norepinephrine Bitartrate In 0.9% Sodium Chloride is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10888534 Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags 26 Apr, 2039
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norepinephrine Bitartrate In 0.9% Sodium Chloride's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List